Empowering Clinicians With Advanced Regenerative Solutions: Dentsply Sirona’s Symbios Allograft

Dentsply Sirona is committed to delivering solutions that advance dentistry for the best patient outcomes and empower dental professionals. The recently enhanced Symbios Allograft mineralized and demineralized line of regenerative solutions is designed for a wide range of dental surgery and implant needs—helping promote bone formation, volume, and stability for predictable, long-term outcomes. The updated portfolio includes new granule allografts, putty products, and the acellular dermal matrix, Symbios PerioDerm.

The modified Symbios Allograft granule size range delivers excellence in purity and precision.

“The updates to our Symbios Allograft portfolio were introduced with the needs of both clinicians and patients in mind, offering predictable handling every step of the way,” said Tony Susino, GVP of implant & prosthetic solutions at Dentsply Sirona. “Our enhanced range is a testament to scientific rigor, continuing our legacy of excellence in precision and sterility to deliver fast and accurate results that both clinicians and patients can rely on.”

Advance Regenerative Practices With Confidence—Excellence in Safety, Sterility, and Precision

The Symbios Allograft range now features a wide variety of mineralized and demineralized granules, as well as mixtures of both, with newly selected granule sizes for enhanced performance and versatility. The allografts adhere to the strictest standards of donor screening, disinfection, cleaning, preservation, and inspection, with minimal manipulation to preserve tissue integrity.

“I have been utilizing the new Symbios Allograft bone graft granule portfolio for some time now. The size and texture of the granules allowed them to mix well with blood concentrate materials at the time of placement, resulting in good handling properties. The most satisfying part is the uncovering; seeing fewer particles always gives me comfort, knowing we were able to develop vital bone,” said Dr. Sausha Toghranegar, periodontist.

Collaborations With Two Trusted Companies to Develop the New Granule, Dermis, and Putty Products

Dentsply Sirona works with RegenX for the granule portfolio, which utilizes the patented Excellion process for bone processing procedures, offering mineralized and demineralized cortical and cancellous granules, as well as a mixture of both. The granules are designed for a wide range of regenerative applications, offering enhanced performance and versatility.

Dentsply Sirona has also continued its long-term relationship with MTF Biologics to deliver dermis and putty products. DBX Putty offers a prefilled, ready-to-use syringe of demineralized bone putty, while the PerioDerm Acellular Dermis soft tissue graft is processed to preserve its extracellular matrix while removing cellular components.

Both companies are accredited by the American Association of Tissue Banks and registered with the FDA. In addition, they provide donated tissues that undergo rigorous donor screening criteria, with less than 2% of donations accepted.*

For more information about Symbios Allograft, visit https://www.dentsplysirona.com/en-us/discover/discover-by-brand/symbios.html.

* Reference – Data on file

Registered brands, trade names and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for use of their experiences and testimonials.

About Dentsply Sirona

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands.

Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care.

Dentsply Sirona’s headquarter is located in Charlotte, North Carolina. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY.

Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

DISCLAIMER

This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements.

In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share, and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks, and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties, and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market, and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.